Nucor earnings beat by $0.08, revenue fell short of estimates
Investing.com - Avita Medical (NASDAQ: RCEL) reported fourth quarter EPS of $-0.44, $0.10 worse than the analyst estimate of $-0.34. Revenue for the quarter came in at $18.4M versus the consensus estimate of $23.2M.
Guidance
Avita Medical sees FY 2025 revenue of $100.00M-$106.00M versus the analyst consensus of $89.70M.
Avita Medical’s stock price closed at $8.78. It is down -26.53% in the last 3 months and down -49.25% in the last 12 months.
Avita Medical saw 0 positive EPS revisions and 5 negative EPS revisions in the last 90 days. See Avita Medical’s stock price’s past reactions to earnings here.
According to InvestingPro, Avita Medical’s Financial Health score is "fair performance".
Check out Avita Medical’s recent earnings performance, and Avita Medical’s financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar